Skip to search formSkip to main contentSkip to account menu

MGS 0039

Known as: MGS-0039, MGS0039 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Produtividade dos trigos MGS 1-Aliança e BRS 404 em função da disponibilidade de água no solo.
A disponibilidade de água no solo é um fator condicionante da produtividade dos cultivos nas principais regiões agrícolas do… 
2014
2014
Composição mineral de folhas de Oliveira (Olea europaea L.) em sistema de produção convencional
This study aimed to quantify the mineral composition of olive leaves to diagnose nutritional status of plants grown in… 
Review
2012
Review
2012
[The potential of group II metabotropic glutamate receptor antagonists as a novel antidepressant].
Recently, abnormalities of glutamatergic transmission have been implicated in the pathophysiology of depression. Moreover, both… 
Highly Cited
2011
Highly Cited
2011
Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists
2011
2011
Anxiolytic-like activity of MGS0039, a selective group II mGlu receptor antagonist, is serotonin- and GABA-dependent
2011
2011
Prenatal exposure to 1-bromopropane modulates the right-left asymmetry in the hippocampal excitability of the rat offspring
2010
2010
Glutamatergic Modulators for the Treatment of Major Depressive Disorder: Metabotropic Glutamate Receptors
The majority of antidepressants facilitate monoamine neurotransmission within the central nervous system as their initial… 
2009
2009
Kömürden Piritik Kükürt Ve Marnın MGS İle Uzaklaştırılması
Cevre kirlili g i gunumuzde uygar toplumlar i n en onemli sorunlar i ndan biridir. Giderek artan endustrile s me ile do g a cok… 
2006
2006
Prodrugs of 3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039): a potent and orally active group II mGluR antagonist with antidepressant-like potential.
2006
2006
IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND BIOAVAILABILITY OF ESTER PRODRUGS OF MGS0039 (3-(3,4-DICHLOROBENZYLOXY)-2-AMINO-6-FLUOROBICYCLO[3.1.0]HEXANE-2,6-DICARBOXYLIC ACID), A POTENT…
MGS0039 (3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo-[3.1.0]hexane-2,6-dicarboxylic acid) has been identified as a potent… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)